<VariationArchive VariationID="222522" VariationName="NM_001232.4(CASQ2):c.546del (p.Phe182fs)" VariationType="Deletion" Accession="VCV000222522" Version="10" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-29" DateCreated="2016-03-01" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="224177" VariationID="222522">
      <GeneList>
        <Gene Symbol="CASQ2" FullName="calsequestrin 2" GeneID="845" HGNC_ID="HGNC:1513" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="115700021" stop="115768714" display_start="115700021" display_stop="115768714" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="116242623" stop="116311425" display_start="116242623" display_stop="116311425" Strand="-" />
          </Location>
          <OMIM>114251</OMIM>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_001232.4(CASQ2):c.546del (p.Phe182fs)</Name>
      <CanonicalSPDI>NC_000001.11:115732960:AAAA:AAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="115732961" stop="115732961" display_start="115732961" display_stop="115732961" variantLength="1" positionVCF="115732960" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="116275582" stop="116275582" display_start="116275582" display_stop="116275582" variantLength="1" positionVCF="116275581" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F182fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.116275585del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.116275585del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.115732964del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.115732964del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008802.1" sequenceAccession="NG_008802" sequenceVersion="1" change="g.40845del">
            <Expression>NG_008802.1:g.40845del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001232.4" sequenceAccession="NM_001232" sequenceVersion="4" change="c.546del" MANESelect="true">
            <Expression>NM_001232.4:c.546del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001223.2" sequenceAccession="NP_001223" sequenceVersion="2" change="p.Phe182fs">
            <Expression>NP_001223.2:p.Phe182fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_404" sequenceAccession="LRG_404">
            <Expression>LRG_404:g.40845del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001232.3" sequenceAccession="NM_001232" sequenceVersion="3" change="c.546delT">
            <Expression>NM_001232.3:c.546delT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_404t1" sequenceAccession="LRG_404t1">
            <Expression>LRG_404t1:c.546del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA351370" DB="ClinGen" />
        <XRef Type="rs" ID="763955301" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001232.4(CASQ2):c.546del (p.Phe182fs) AND Catecholaminergic polymorphic ventricular tachycardia 1" Accession="RCV000208054" Version="11">
        <ClassifiedConditionList TraitSetID="6589">
          <ClassifiedCondition DB="MedGen" ID="C1631597">Catecholaminergic polymorphic ventricular tachycardia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-07-28" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001232.4(CASQ2):c.546del (p.Phe182fs) AND multiple conditions" Accession="RCV002485356" Version="8">
        <ClassifiedConditionList TraitSetID="9919">
          <ClassifiedCondition DB="MedGen" ID="C1631597">Catecholaminergic polymorphic ventricular tachycardia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2677794">Catecholaminergic polymorphic ventricular tachycardia 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-03" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001232.4(CASQ2):c.546del (p.Phe182fs) AND Cardiovascular phenotype" Accession="RCV003165506" Version="9">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001232.4(CASQ2):c.546del (p.Phe182fs) AND Catecholaminergic polymorphic ventricular tachycardia 2" Accession="RCV003338461" Version="1">
        <ClassifiedConditionList TraitSetID="6678">
          <ClassifiedCondition DB="MedGen" ID="C2677794">Catecholaminergic polymorphic ventricular tachycardia 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-11" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-28" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2016-03-01" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12386154</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19398665</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21618644</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29544605</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32693635</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6589" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4488" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Stress-induced polymorphic ventricular tachycardia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC 1</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Catecholaminergic polymorphic ventricular tachycardia 1</ElementValue>
                <XRef ID="MONDO:0011484" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CPVT1</ElementValue>
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP1</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias self-terminate. In other instances, ventricular tachycardia may degenerate into ventricular fibrillation and cause sudden death if cardiopulmonary resuscitation is not readily available. The mean onset of symptoms (usually a syncopal episode) is between age seven and 12 years; onset as late as the fourth decade of life has been reported. If untreated, CPVT is highly lethal, as approximately 30% of affected individuals experience at least one cardiac arrest and up to 80% have one or more syncopal spells. Sudden death may be the first manifestation of the disease.</Attribute>
                <XRef ID="NBK1289" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301466</ID>
                <ID Source="BookShelf">NBK1289</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="3286" DB="Orphanet" />
              <XRef ID="C1631597" DB="MedGen" />
              <XRef ID="MONDO:0011484" DB="MONDO" />
              <XRef Type="MIM" ID="604772" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9919" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4488" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Stress-induced polymorphic ventricular tachycardia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC 1</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Catecholaminergic polymorphic ventricular tachycardia 1</ElementValue>
                <XRef ID="MONDO:0011484" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CPVT1</ElementValue>
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP1</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP</ElementValue>
                <XRef Type="MIM" ID="604772" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias self-terminate. In other instances, ventricular tachycardia may degenerate into ventricular fibrillation and cause sudden death if cardiopulmonary resuscitation is not readily available. The mean onset of symptoms (usually a syncopal episode) is between age seven and 12 years; onset as late as the fourth decade of life has been reported. If untreated, CPVT is highly lethal, as approximately 30% of affected individuals experience at least one cardiac arrest and up to 80% have one or more syncopal spells. Sudden death may be the first manifestation of the disease.</Attribute>
                <XRef ID="NBK1289" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301466</ID>
                <ID Source="BookShelf">NBK1289</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="3286" DB="Orphanet" />
              <XRef ID="C1631597" DB="MedGen" />
              <XRef ID="MONDO:0011484" DB="MONDO" />
              <XRef Type="MIM" ID="604772" DB="OMIM" />
            </Trait>
            <Trait ID="5103" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC 2</ElementValue>
                <XRef Type="MIM" ID="611938" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Catecholaminergic polymorphic ventricular tachycardia 2</ElementValue>
                <XRef ID="MONDO:0012762" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CPVT2</ElementValue>
                <XRef Type="MIM" ID="611938" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP2</ElementValue>
                <XRef Type="MIM" ID="611938" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias self-terminate. In other instances, ventricular tachycardia may degenerate into ventricular fibrillation and cause sudden death if cardiopulmonary resuscitation is not readily available. The mean onset of symptoms (usually a syncopal episode) is between age seven and 12 years; onset as late as the fourth decade of life has been reported. If untreated, CPVT is highly lethal, as approximately 30% of affected individuals experience at least one cardiac arrest and up to 80% have one or more syncopal spells. Sudden death may be the first manifestation of the disease.</Attribute>
                <XRef ID="NBK1289" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15535" />
                <XRef ID="15535" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301466</ID>
                <ID Source="BookShelf">NBK1289</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="3286" DB="Orphanet" />
              <XRef ID="C2677794" DB="MedGen" />
              <XRef ID="MONDO:0012762" DB="MONDO" />
              <XRef Type="MIM" ID="611938" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6678" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5103" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VENTRICULAR TACHYCARDIA, STRESS-INDUCED POLYMORPHIC 2</ElementValue>
                <XRef Type="MIM" ID="611938" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Catecholaminergic polymorphic ventricular tachycardia 2</ElementValue>
                <XRef ID="MONDO:0012762" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CPVT2</ElementValue>
                <XRef Type="MIM" ID="611938" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VTSIP2</ElementValue>
                <XRef Type="MIM" ID="611938" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias self-terminate. In other instances, ventricular tachycardia may degenerate into ventricular fibrillation and cause sudden death if cardiopulmonary resuscitation is not readily available. The mean onset of symptoms (usually a syncopal episode) is between age seven and 12 years; onset as late as the fourth decade of life has been reported. If untreated, CPVT is highly lethal, as approximately 30% of affected individuals experience at least one cardiac arrest and up to 80% have one or more syncopal spells. Sudden death may be the first manifestation of the disease.</Attribute>
                <XRef ID="NBK1289" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15535" />
                <XRef ID="15535" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301466</ID>
                <ID Source="BookShelf">NBK1289</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="3286" DB="Orphanet" />
              <XRef ID="C2677794" DB="MedGen" />
              <XRef ID="MONDO:0012762" DB="MONDO" />
              <XRef Type="MIM" ID="611938" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="493610" SubmissionDate="2016-01-15" DateLastUpdated="2016-03-01" DateCreated="2016-03-01">
        <ClinVarSubmissionID localKey="NM_001232.3:c.546delT|MedGen:C1631597" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000263805" DateUpdated="2016-03-01" DateCreated="2016-03-01" Type="SCV" Version="2" SubmitterName="Blueprint Genetics" OrgID="500188" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-01-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19398665</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21618644</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Variant Classification</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/5yj8a71c/variant_classification_wp_vara41-03.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CASQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001232.3:c.546delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1631597" Type="CUI" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5431167" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_001232.4:c.546del|OMIM:604772;611938" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002776660" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001232.4:c.546del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604772" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611938" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7575760" SubmissionDate="2023-10-18" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="NM_001232.4:c.546del|OMIM:611938" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004048931" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CASQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001232.4:c.546del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611938" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13910671</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4218109" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="597863|MedGen:C1631597" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002198977" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12386154</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19398665</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21618644</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29544605</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32693635</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe182Leufs*28) in the CASQ2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CASQ2 are known to be pathogenic (PMID: 12386154). This variant is present in population databases (rs763955301, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with clinical features of catecholaminergic polymorphic ventricular tachycardia (PMID: 19398665, 21618644, 29544605, 32693635). ClinVar contains an entry for this variant (Variation ID: 222522). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CASQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.116275582del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1631597" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7215308" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2023-04-15">
        <ClinVarSubmissionID localKey="a157869|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003866688" DateUpdated="2024-05-01" DateCreated="2023-04-15" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19398665</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21618644</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29544605</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32693635</ID>
          </Citation>
          <Comment>The c.546delT pathogenic mutation, located in coding exon 5 of the CASQ2 gene, results from a deletion of one nucleotide at nucleotide position 546, causing a translational frameshift with a predicted alternate stop codon (p.F182Lfs*28). This variant co-occurred in trans with a second CASQ2 variant in a proband reported to have catecholaminergic polymorphic ventricular tachycardia (CPVT) (Roux-Buisson N et al. Hum Mutat, 2011 Sep;32:995-9). This variant has also been detected in a case of sudden infant death and an additional CVPT cohort; however, details were limited (Tester DJ et al. J Am Coll Cardiol, 2018 Mar;71:1217-1227). (Ng K et al. Circulation, 2020 Sep;142:932-947). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CASQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001232.3:c.546delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough031523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7215308" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4218109" TraitType="Disease" MappingType="XRef" MappingValue="C1631597" MappingRef="MedGen">
        <MedGen CUI="C1631597" Name="Catecholaminergic polymorphic ventricular tachycardia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="493610" TraitType="Disease" MappingType="XRef" MappingValue="C1631597" MappingRef="MedGen">
        <MedGen CUI="C1631597" Name="Catecholaminergic polymorphic ventricular tachycardia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575760" TraitType="Disease" MappingType="XRef" MappingValue="611938" MappingRef="OMIM">
        <MedGen CUI="C2677794" Name="Catecholaminergic polymorphic ventricular tachycardia 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5431167" TraitType="Disease" MappingType="XRef" MappingValue="604772" MappingRef="OMIM">
        <MedGen CUI="C1631597" Name="Catecholaminergic polymorphic ventricular tachycardia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5431167" TraitType="Disease" MappingType="XRef" MappingValue="611938" MappingRef="OMIM">
        <MedGen CUI="C2677794" Name="Catecholaminergic polymorphic ventricular tachycardia 2" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002016928</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

